UNH vs ELV
UNH and ELV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | UNHUnitedHealth Group Incorporated | ELVElevance Health, Inc. |
|---|---|---|
| Market cap | $360.55B | $89.65B |
| P/E (TTM) | 25.8 | 17.6 |
| P/B | 10.92 | 2.01 |
| P/S | 0.8x | 0.4x |
| Dividend yield | 2.20% | 1.71% |
| Revenue | $450.13B(TTM) | $201.83B(TTM) |
| Revenue growth (YoY) | 11.8% | 12.5% |
| Net income | $14.12B(TTM) | $5.14B(TTM) |
| Earnings growth (YoY) | -16.3% | -5.3% |
| EPS, diluted | $15.56(TTM) | $23.55(TTM) |
| EBIT margin | 4.2% | 3.6% |
| ROE | 36.5% | 12.7% |
| ROIC | 21.3% | 9.4% |
| 1y total return | +22.6% | +34.7% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: UNH vs ELV
| Metric | UNH | ELV |
|---|---|---|
| End value | $33.8K | $36.4K |
| Total return | +238.1% | +263.6% |
| CAGR | +12.5% | +13.3% |
| Volatility | 30.0% | 31.0% |
| Sharpe | 0.41 | 0.42 |
| Sortino | 0.56 | 0.60 |
| Max drawdown | -61.4% | -50.4% |
Based on 2600 common trading days, 2016-07-01 → 2026-11-03 · risk-free 4.21% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)